Replies to post #10687 on Value Microcaps Zip Code Changers

[RNsidersbuying]

NBIO .125 - The only company with a target for vimentim is Nascent Biotech Inc. (OTCMKT: NBIO). Their lead candidate is pritumumab which was a phase 2 brain cancer asset in Japan. They have redone their cell line for study and on the cusp of starting their phase 1 cancer trial.

https://insiderfinancial.com/top-coronavirus-stocks-backed-by-scientific-evidence/179657/